(1)
Schlesinger, T.; Lebwohl, M.; Del Rosso, J.; Patel, V. A.; Kircik, L.; Armstrong, A.; Berman, B.; Rigel, D.; Narayanan, S.; Koscielny, V.; Kasujee, I.; Bhatia, N. Safety and Tolerability of Tirbanibulin 1% Treatment of Actinic Keratosis on Face and Scalp in Routine Clinical Practice Across the U.S. (PROAK Study). J of Skin 2023, 7, s263.